stocktools
Offerings // NeuroSense Therapeutics Ltd.

NRSN offering history

Every offering-related filing in NeuroSense Therapeutics Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 301 filings back to Aug 9, 2021.

Last executed offering
Aug 8, 2025
424B5 — priced deal (shares or notes)
Last registration (announced)
Jul 30, 2026
F-3/A — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
3
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 30, 2026F-3/AREGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Jan 29, 2026F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 26, 2025424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 25, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Oct 28, 2025F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Aug 18, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Aug 18, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Aug 8, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 16, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 16, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Feb 21, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 17, 2025424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 16, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 26, 2024F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 12, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 12, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 6, 2024F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 22, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 22, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Nov 19, 2024F-1REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Oct 4, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Aug 16, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 27, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 27, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 17, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 17, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
May 22, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
May 22, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
May 20, 2024F-1/AREGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 10, 2024F-1REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Apr 12, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 8, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 8, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 27, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 14, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 5, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 5, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 4, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Sep 7, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 5, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
NRSN offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full NRSN workspace →
NRSN offering FAQ

When did NRSN last execute an offering?

Per SEC filings, NeuroSense Therapeutics Ltd.'s most recent priced offering document is a 424B5 filed 2025-08-08. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did NRSN last announce or register an offering?

The most recent registration is a F-3/A filed 2026-07-30. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.